NMS Group

NMS Group

Research Services Nerviano, Milano, IT 112 employees
Employees
112
Contacts
1
Emails
1

NMS Group Overview

Headquarters
Nerviano, Milano, IT
Website
nmsgroup.it
Industry
Research Services
Employees
112
Funding
220.9M
Company Email
Available in AeroLeads
NAICS
Scientific Research and Development Services
Research and Development in the Physical, Engineering, and Life Sciences
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

About NMS Group

NMS Group, Italy's largest oncology-focused R&D company, employs over 400 individuals, with more than half in advanced research and manufacturing roles. Its kinase inhibitor and antibody-conjugate platforms drive innovation, establishing NMS as a global leader in personalized therapies. Notably, NMS discovered entrectinib, a targeted kinase inhibitor for NTRK1/2/3 and ROS1-dependent tumors, now commercialized globally through Roche. The Group includes three subsidiaries: NMS S.r.l., focused on FIC/BIC cancer drug development with a dozen active projects; Accelera, a preclinical CRO; and NerPharMa, which manufactures APIs and drug products for clinical and commercial use.

NMS Group Contact Details

People in AeroLeads
4
With contact data
1
Email contacts
1
25.0% coverage

NMS Group Org Chart

Sample employees and titles
Name Title Contact
Kim Ginnerup
View
Gabriele Valerio Database and Data Manager at Nerviano Medical Sciences
Email
Arianna Startari Senior Legal Counsel at Nms Group
View
Marcello P. R&D Chief Cmc Innovation Officer
View

Employees by Management Level

Individual contributor 15 profiles
Manager 6 profiles
Senior / Lead 2 profiles
Executive 1 profile
VP / Head 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 4 4 0
Healthcare 3 3 0
Sales 1 1 0

NMS Group Tech Stack

Data / AI 2 profiles

Compare Similar Companies to NMS Group